Response by Solomon to Letter Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study"

Circulation. 2019 Jul 9;140(2):e92-e93. doi: 10.1161/CIRCULATIONAHA.119.040941. Epub 2019 Jul 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amyloid Neuropathies, Familial / genetics*
  • Humans
  • Prealbumin / genetics*
  • RNA Interference
  • RNA, Small Interfering

Substances

  • Prealbumin
  • RNA, Small Interfering
  • patisiran